Anti-Aging · Reference
Topical GHK-Cu vs Injectable GHK-Cu: Evidence, Safety, Cost and Which Fits
This page explains each form on its own terms, puts them side by side, covers what the research does and does not show, side effects and the copper question, where GHK-Cu stands with the FDA, how Pepti doses the injection, what it costs, and who tends to suit which.
Topical GHK-Cu (a copper peptide serum or cream) and injectable GHK-Cu contain the same copper-binding tripeptide, but they are different products: a topical acts on the outer layers of the skin it is applied to, while an injection under the skin delivers the whole dose into the body. The human evidence for GHK-Cu is almost entirely topical: small studies of creams in photoaged facial skin and a 1994 study of a topical gel in diabetic ulcers. The injectable has cell studies, animal studies and injected-mouse work, but no randomized human trials. Neither has been shown to do what the other does, and no study has compared them. Pepti prescribes injectable GHK-Cu, which is compounded and not FDA approved; cosmetic serums are sold without a prescription.
This page explains each form on its own terms, puts them side by side, covers what the research does and does not show, side effects and the copper question, where GHK-Cu stands with the FDA, how Pepti doses the injection, what it costs, and who tends to suit which.
Topical GHK-Cu vs Injectable GHK-Cu
The short answer
| If what you want is | The usual choice | What it involves | Price |
|---|---|---|---|
| Topical skin care for the face | A copper peptide serum or cream | Applied to skin; sold as a cosmetic, no prescription | Not supplied by Pepti |
| GHK-Cu by injection, on its own | GHK-Cu | 50 mg in a 5 mL vial; 0.25 mL under the skin Monday through Friday | $239/mo |
| GHK-Cu with tesamorelin | RADIANCE Blend | 50 mg GHK-Cu, 10 mg tesamorelin in 5 mL | $249/mo |
| GHK-Cu with soft-tissue repair peptides | GLOW | 50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500 in 5 mL | $259/mo |
| GHK-Cu with repair peptides and KPV | KLOW | 50 mg GHK-Cu, 10 mg KPV, 10 mg BPC-157, 10 mg TB-500 in 5 mL | $259/mo |
Pepti's prices are all-in, covering medication, physician review, refill management and shipping, with no separate membership fee. Pepti is cash-pay and does not bill insurance.
Topical GHK-Cu vs Injectable GHK-Cu
GHK-Cu itself, briefly
GHK-Cu is a tripeptide, glycine, histidine and lysine, bound to a copper ion. It occurs naturally in human plasma and was first described in a 1973 paper in Nature: New Biology as a component of human serum that prolonged the survival of liver cells in culture. Its described role is carrying copper in a form that is not free and reactive to copper-dependent enzymes, including lysyl oxidase, which cross-links newly made collagen into fibers. The copper is also why the solution is blue; why is GHK-Cu blue explains what a normal vial looks like. The full reference is what is GHK-Cu.
Topical GHK-Cu vs Injectable GHK-Cu
Topical GHK-Cu on its own terms
What it is
Copper peptide serums and creams are cosmetics: regulated as consumer products, sold without a prescription, and frequently silent on how much GHK-Cu they contain. That is not a criticism. A cosmetic is not required to be dosed, and it is meant to act on the skin it is applied to.
What human data exists
The topical route is where nearly all the human GHK-Cu data lives.
Study What was applied Who What was reported Wound Repair and Regeneration, 1994 Topical GHK-Cu gel Patients with diabetic ulcers Improved ulcer closure compared with the comparison dressing Archives of Facial Plastic Surgery, 2006 Topical copper tripeptide skin care after CO2 laser resurfacing 13 patients, randomized Blinded evaluators found no objective difference in redness or wrinkles; patient-reported satisfaction was higher Cosmetic-science studies summarized in a 2015 BioMed Research International review GHK-Cu creams Mostly women with photoaged facial skin, 8 to 12 weeks Changes in skin density, thickness, firmness, fine lines and clarity, measured by instruments and dermatologists The caveats are real. Most of the cosmetic work appeared in conference proceedings and industry-funded reports rather than peer-reviewed journals. A 2009 review in the International Journal of Cosmetic Science surveyed the peptides used in anti-aging topicals, copper peptides included, and found most supporting studies small, short and industry-run. In short: real human data, small studies, topical route, cosmetic endpoints.
How far a topical gets
A 2011 paper in Inflammation Research measured how much of a copper tripeptide penetrates human skin in vitro, layer by layer, and found that very little reaches deeper tissue. A serum's copper tripeptide mostly stays in the outer skin, which is what a serum is for. That is also why a topical does not carry the systemic copper question an injection does.
Topical GHK-Cu vs Injectable GHK-Cu
Injectable GHK-Cu on its own terms
What it is
A sterile solution of GHK-Cu in a multi-dose vial, prepared by a state-licensed, FDA-registered compounding pharmacy against a prescription written for you by a physician licensed in your state, and injected into the fat layer of the abdomen or thigh. At Pepti the single-agent vial is 5 mL at 10 mg/mL (50 mg), and the directions are 0.25 mL (25 units on a U-100 insulin syringe) once daily Monday through Friday. That is 2.5 mg per dose, twenty doses per vial, about four weeks. Every Pepti blend that contains GHK-Cu carries it at the same 10 mg/mL.
What the research describes
The injectable rests on three kinds of work, none of it in people:
Line of research What was reported Evidence type Collagen and matrix synthesis GHK-Cu stimulated collagen synthesis in cultured human fibroblasts (FEBS Letters, 1988); increased connective tissue in rat wound chambers (Journal of Clinical Investigation, 1993) Cell and animal Tissue remodelling Modulated matrix metalloproteinases in rat wounds (1999) and fibroblast cultures (2000) Animal and cell Systemic dosing in mice Reduced inflammatory markers and structural damage in models of acute lung injury (Oncotarget, 2016), fibrosis (Life Sciences, 2020) and emphysema (Frontiers in Molecular Biosciences, 2022) Animal, systemic Gene expression GHK's gene signature ran opposite to emphysema-related lung destruction (Genome Medicine, 2012) Computational and cell The injected-mouse work matters because it is the only body of research that used a systemic route, the closest the literature gets to what Pepti supplies. It establishes that systemic GHK-Cu does something measurable in rodents. It does not establish what it does in a person.
What human data exists
There are no randomized controlled trials of injectable GHK-Cu in humans, and no published human pharmacokinetic study showing that subcutaneous GHK-Cu reaches skin, hair follicles or connective tissue at a concentration comparable to the cell studies. Prescribers who use the injectable for skin and tissue-quality goals have clinical experience, and that is what the injectable conversation rests on, along with the collagen mechanism.
Topical GHK-Cu vs Injectable GHK-Cu
Head to head
| Topical GHK-Cu | Injectable GHK-Cu | |
|---|---|---|
| What it is | A cosmetic serum or cream | A sterile compounded solution |
| Prescription | No | Yes |
| Who makes it | A cosmetics manufacturer | A licensed compounding pharmacy |
| Concentration disclosed | Often not | On the prescription label |
| Where it acts | The outer layers of the skin it is applied to | The whole body, after injection under the skin |
| Human studies | Small studies of creams in photoaged skin; a 1994 topical gel study in diabetic ulcers; a 2006 post-laser study | None |
| Other evidence | Skin-penetration work showing little reaches deeper tissue | Cell studies, rat wound studies, injected-mouse lung studies |
| Copper load assessed against your history | Not applicable | Yes, by your physician |
| Typical concerns | Not described in the sources behind this page beyond being a local product | Site redness or stinging, a faint blue-green mark, copper cautions |
| Head-to-head trial | None | None |
| At Pepti | Not supplied | $239/mo on its own; $249 to $259/mo in the blends above |
The real difference is route, not strength
People often ask whether the injection is a "stronger serum." It is not. The two differ in exposure: a serum mostly stays in the outer skin, and an injection delivers the whole dose systemically. The serum has the human skin data; the injection has the systemic exposure, mouse studies and prescriber experience. A source that quotes the cream studies as proof the injection works is conflating two routes, and a seller describing one as the other is describing something untrue. Many people use a serum and never need a prescription at all.
Topical GHK-Cu vs Injectable GHK-Cu
What the evidence shows, honestly
GHK-Cu is well characterized in cells and animals, human-studied as a topical, and prescribed as an injection on the strength of mechanism plus clinical experience. That is a reasonable basis for a physician to prescribe it. It is not evidence that the injection does what the creams were reported to do, and it is not evidence that an injection adds anything to a topical, because no study has compared the two. Even the topical evidence is modest: small, short, mostly industry-funded, and in the one randomized post-laser study blinded evaluators found no objective difference. Sunscreen and a retinoid have more human evidence behind them than any peptide, and a dermatologist belongs in the picture for anything that changes or will not heal. The benefit-by-benefit picture is in GHK-Cu benefits, and the wider skin question in peptides for skin.
Topical GHK-Cu vs Injectable GHK-Cu
Side effects and the copper question
Topical. A serum is a local product, and skin-penetration work shows how little reaches deeper layers, which is why the systemic copper question does not apply to it.
Injectable.
| What is reported | How often | What it means |
|---|---|---|
| Injection-site redness, itching, stinging or a small lump | Common; stinging is more common than with other repair peptides | Usually irritation; rotate sites |
| A faint blue-green mark at the site | Common | Copper that has not yet dispersed; clears on its own |
| Nausea or a metallic taste | Uncommon | Tell your physician |
| Headache or light-headedness after dosing | Uncommon | Tell your physician, especially if you take blood-pressure medication |
| Persistent vomiting, abdominal pain, jaundice or new confusion | Not reported at prescribed doses | The pattern of copper excess; stop and contact your physician |
| Facial or throat swelling, widespread rash, breathing difficulty | Rare | Call 911, then tell your prescriber |
The cautions specific to injectable GHK-Cu are copper cautions. Anyone with Wilson's disease or another copper-metabolism disorder should not use it. Significant liver disease narrows the margin, because the liver is the body's copper exit route. High-dose zinc belongs on the intake because zinc and copper compete. Two GHK-Cu products at once means double the copper; a blend carries one copper dose, and a standalone vial alongside a GHK-Cu blend carries two. GHK-Cu also has a described role in new blood-vessel growth (Journal of Cell Biology, 1994), which is why a personal history of cancer is raised with your physician; see can peptides cause cancer. It is not used in pregnancy or breastfeeding. More is in is GHK-Cu safe.
Topical GHK-Cu vs Injectable GHK-Cu
Where GHK-Cu stands with the FDA
Injectable GHK-Cu was placed in Category 2 of the FDA's interim 503A bulk substances list in September 2023, the category for nominated substances flagged as raising significant safety concerns. Non-injectable GHK-Cu sat separately in Category 1. On 15 April 2026 the FDA removed twelve peptides from Category 2, injectable GHK-Cu among them, and at the same time removed GHK-Cu from Category 1 because the nomination that had placed it there was withdrawn. The FDA has said its Pharmacy Compounding Advisory Committee will review GHK-Cu before the end of February 2027. It remains legal to prescribe and dispense, and compounded medications are not FDA approved. Cosmetic serums are regulated as consumer products, not as drugs. Are peptides FDA approved explains the difference between not approved and not legal.
Topical GHK-Cu vs Injectable GHK-Cu
Dosing and logistics at Pepti
| Detail | GHK-Cu injection |
|---|---|
| Vial | 5 mL multi-dose vial, 10 mg/mL (50 mg) |
| Directions | 0.25 mL (25 units) subcutaneously once daily Monday through Friday |
| GHK-Cu per dose | 2.5 mg (10 mg/mL x 0.25 mL) |
| Doses per vial | 20, about four weeks |
| Price | $239/mo, all-in |
Your physician sets your directions after reviewing your intake, and your exact dose is printed on the vial. Refills run every 28 days, one vial per fill. Each vial is a multi-dose solution shipped ready to use, refrigerated with ice packs, with sterile syringes and alcohol prep pads. Nothing is mixed at home.
Topical GHK-Cu vs Injectable GHK-Cu
Who suits which
A topical serum
A serum suits someone whose goal is topical skin care for the face, who wants the route with the human skin studies behind it, and who does not want an injection or a prescription. If that is all you want, a serum from a cosmetics retailer is a reasonable purchase.
Injectable GHK-Cu
The injection suits someone whose goal is skin and connective tissue more broadly, who wants a prescribed product from a pharmacy accountable for sterility and concentration, with their copper load reviewed against their history, and who understands that the injectable has no human trials. Some people use both; the two are not interchangeable in either direction.
A blend
When there is a soft-tissue complaint alongside the skin goal, GLOW adds BPC-157 and TB-500 in one vial; when inflammation is part of the picture, KLOW adds KPV as well. KLOW vs GLOW sets them side by side. RADIANCE pairs GHK-Cu with tesamorelin; see what is RADIANCE.
Neither, first
Situation What makes more sense A skin change that is new, growing or will not heal A dermatologist first Wilson's disease or another copper disorder Not GHK-Cu by injection Pattern hair loss No GHK-Cu trial has hair growth as its endpoint; see peptides for hair growth Pigment or skin tone GHK-Cu is described around collagen, not pigment; see glutathione for skin for what that research looked at Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
Topical GHK-Cu vs Injectable GHK-Cu
Where to get injectable GHK-Cu prescribed
Injectable GHK-Cu cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for identity, purity, sterility or concentration. The prescription route:
- Complete a free online intake covering your history, medications and what you want help with, including any zinc supplement and any other GHK-Cu product.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your physician stays reachable for questions and side effects.
Pepti prescribes GHK-Cu in every state except Oklahoma, plus DC Step by step: how to get GHK-Cu prescribed online. What to check on any seller is in where to buy GHK-Cu online.
References
What this is based on.
References
- Maquart FX, Pickart L, Laurent M, et al.. Stimulation of collagen synthesis in cultured fibroblasts by GHK-Cu · FEBS Letters (1988) · PMID 3169264
- Pickart L, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration · BioMed Research International (2015) · PMID 26236730
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data · International Journal of Molecular Sciences (2018) · PMID 29986520
- Pickart L. The human tri-peptide GHK and tissue remodeling · Journal of Biomaterials Science, Polymer Edition (2008) · PMID 18644225
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver · Nature: New Biology (1973) · PMID 4349963
- Lane TF, et al.. SPARC is a source of copper-binding peptides that stimulate angiogenesis · Journal of Cell Biology (1994) · PMID 7514608
- Maquart FX, et al.. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds · Journal of Clinical Investigation (1993) · PMID 8227353
- Mulder GD, et al.. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper · Wound Repair and Regeneration (1994) · PMID 17147644
- Siméon A, et al.. Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ · Journal of Investigative Dermatology (1999) · PMID 10383745
- Siméon A, et al.. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures · Life Sciences (2000) · PMID 11045606
- Miller TR, et al.. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin · Archives of Facial Plastic Surgery (2006) · PMID 16847171
- Pyo HK, et al.. The effect of tripeptide-copper complex on human hair growth in vitro · Archives of Pharmacal Research (2007) · PMID 17703734
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Topical GHK-Cu vs Injectable GHK-Cu, answered.
They are different products for different purposes rather than better and worse. The topical has the human skin data; the injection has systemic exposure, animal studies and prescriber experience. No study has compared them.
Nobody knows, because no study has tested it. The cream studies describe what a cream did on the skin it was applied to; they do not describe what an injection into the abdomen does to the face.
Small, mostly industry-funded studies of GHK-Cu creams in photoaged facial skin reported changes in density, firmness and fine lines over 8 to 12 weeks. In a 2006 randomized post-laser study, blinded evaluators found no objective difference. The evidence is real but modest.
Not far. A 2011 skin-penetration study in Inflammation Research found very little of a topical copper tripeptide reaches deeper skin layers. A serum mostly acts on the outer skin.
There is no study of the combination. A serum mostly stays in the outer skin, so it does not carry the systemic copper question an injection does, but list every GHK-Cu product you use on your intake.
The common reports are site redness, stinging and a faint blue-green mark. The specific cautions are copper ones: Wilson's disease, significant liver disease, high-dose zinc, and two GHK-Cu products at once. There is no long-term human data for continuous injection. See is GHK-Cu safe.
Under the skin, into the fat layer, with the abdomen and thigh the usual sites, rotated. The injection is systemic rather than aimed at the skin you want to change. Your directions are printed on the vial.
There is no human trial of GHK-Cu, topical or injected, with hair growth as its endpoint. The follicle work is in animals and in human follicles kept in a dish, using a related copper tripeptide.
Because of the copper. A blue solution is expected; why is GHK-Cu blue explains what a normal vial looks like and when one looks wrong.
At Pepti, $239 a month for GHK-Cu alone, all-in, covering medication, physician review, refill management and shipping. RADIANCE is $249, and GLOW and KLOW are $259.
No. Compounded medications are not FDA approved. Injectable GHK-Cu was removed from Category 2 on 15 April 2026 and is due for advisory committee review before the end of February 2027. Cosmetic serums are consumer products, not approved drugs.
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.